The Lancet Haematology in conversation with artwork

Elisabeth Schorb on the MARTA phase 2 trial

The Lancet Haematology in conversation with

English - February 29, 2024 12:00 - 9 minutes - 6.47 MB
Life Sciences Science Education blood haemophilia haematology leukaemia Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
Next Episode: Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia

Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.

Read the full article:
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Twitter Mentions